Msc

(redirected from MSCS)
Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.
Related to MSCS: MCS, Mesenchymal stem cells

MSC

Abbreviation for:
major septic complication
major symptom complex
marrow stem cells
Masters of Science 
Materials Services Center
medial septum complex
Medicaid Service Coordinator
Medical Services Committee  
medical smart card
medical staff corps
Medicare Status Code
medicines selection committee
membrane secretory component
mesenchymal stem cell
mid-systolic click
migrating spike complex
Modernising Scientific Careers, see there 
Moloney sarcoma cell
morphine sulphate
motile sperm count
motor-sensory cortex
myeloid suppressor cells

Msc

Abbrev. for Master of Science.
References in periodicals archive ?
Only a small number of MSCs are needed to seed the dressing, so the product could be produced at a low cost and positioned very competitively against existing treatment options.
MSCs and IFN[alpha]-AF-MSCs from passages 5, 10, 15, and 20 were harvested and resuspended in [alpha]-MEM containing 10% (vol/vol) FBS at a concentration of 1 x 104 cells/ml, plated into 24-well plates at 5000 cells (500 [micro]l) per well, and incubated 24 hours in a humidified 37[degrees]C incubator under 5% C[O.sub.2] to allow the cells to adhere to the plates.
After incubation for 1.5 h, IPTG (isopropyl-[beta]-D-thiogalactoside) was added (final concentration: 1 mM) to induce MscS expression.
In this study, human amniotic membrane as an accessible and valuable source of MSCs was the main focus.
Overall the isolated MSCs from fetal origin are believed to have higher proliferative capacity than MSC from bone marrow.
Culture of Human MSC. Following approval of the local ethics committee and informed consent, human MSC were obtained from the bone marrow aspirates of patients who underwent total hip replacement surgery.
In addition, the consistency of the quorum volume should be maintained in a synchronous manner to guarantee operations of the MSCS cluster independent of any type of failures.
Energy savings may be the initial driving force behind MSCs, but several other benefits can come to those who retrofit:
In spite of cell sources, there are many other practical difficulties in MSC therapies such as the risk of pulmonary embolism, the need for cryogenic storage/shipping and for thawing cryopreserved cells and the related high cost, and dynamic changes of living MSCs caused by various factors such as thawing, shear stress during injection, and in vivo microenvironments.